Health-related quality of life in patients with recurrent pericarditis: results from a phase 2 study of rilonacept

Health-related quality of life in patients with recurrent pericarditis: results from a phase 2 study of rilonacept

Abstract Background Impact of recurrent pericarditis (RP) on patient health-related quality of life (HRQoL) was evaluated through qualitative patient interviews and as an exploratory endpoint in a Phase 2 trial evaluating the efficacy and safety of rilonacept (IL-1α/IL-1β cytokine trap) to treat RP....

Full description

Bibliographic Details
Main Authors: David Lin, Allan Klein, David Cella, Anna Beutler, Fang Fang, Matt Magestro, Paul Cremer, Martin M. LeWinter, Sushil Allen Luis, Antonio Abbate, Andrew Ertel, Leighann Litcher-Kelly, Brittany Klooster, John F. Paolini
Format: Article
Language:English
Published: BMC 2021-04-01
Series:BMC Cardiovascular Disorders
Subjects:
Pericarditis
Interleukin-1 cytokine trap
Health-related quality of life
Recurrent pericarditis
Online Access:https://doi.org/10.1186/s12872-021-02008-3

Internet

https://doi.org/10.1186/s12872-021-02008-3

Similar Items